Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial

J Androl. 2002 Nov-Dec;23(6):763-71.

Authors

Wayne J G Hellstrom¹, Marc Gittelman, Gary Karlin, Thomas Segerson, Marc Thibonnier, Terry Taylor, Harin Padma-Nathan

Affiliation

¹ Department of Urology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA. [email protected]

PMID: 12399521

No abstract available

Publication types

Clinical Trial
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Double-Blind Method
Electrocardiography
Erectile Dysfunction / drug therapy*
Erectile Dysfunction / physiopathology
Humans
Imidazoles / adverse effects
Imidazoles / therapeutic use*
Male
Middle Aged
Penile Erection / drug effects
Phosphodiesterase Inhibitors / adverse effects
Phosphodiesterase Inhibitors / therapeutic use*
Piperazines / adverse effects
Piperazines / therapeutic use*
Placebos / therapeutic use
Recovery of Function
Safety
Sulfones
Treatment Outcome
Triazines
Vardenafil Dihydrochloride

Substances

Imidazoles
Phosphodiesterase Inhibitors
Piperazines
Placebos
Sulfones
Triazines
Vardenafil Dihydrochloride